The Chemours Company provided earning guidance for 2022. Net income attributable to Chemours to be in range of $670 million to $775 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.96 USD | +0.02% | +5.31% | -8.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.18% | 4.31B | |
-0.96% | 74.01B | |
+1.76% | 47.66B | |
+1.59% | 32.76B | |
+10.03% | 18.17B | |
+11.97% | 11.85B | |
-14.66% | 11.16B | |
+2.04% | 10.89B | |
+0.72% | 9.49B | |
-2.13% | 8.35B |
- Stock Market
- Equities
- CC Stock
- News The Chemours Company
- The Chemours Company Provides Earning Guidance for 2022